Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Armata Pharmaceuticals, Inc. (ARMP) had Income from Continuous Operations of $-173.80M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$4.90M |
|
$-173.80M |
|
-- |
|
$4.90M |
|
$41.54M |
|
$-36.63M |
|
$-137.16M |
|
$-173.80M |
|
$-173.80M |
|
$-173.80M |
|
|
Income from Continuous Operations |
$-173.80M |
$-173.80M |
|
$-173.80M |
|
$-36.63M |
|
$-35.10M |
|
36.24M |
|
36.24M |
|
$-4.80 |
|
$-4.80 |
|
| Balance Sheet Financials | |
$10.67M |
|
$12.19M |
|
$66.21M |
|
$76.88M |
|
$8.95M |
|
$256.92M |
|
$286.53M |
|
$295.48M |
|
$-218.60M |
|
$-222.09M |
|
$-218.60M |
|
36.43M |
|
| Cash Flow Statement Financials | |
$-25.76M |
|
$-0.54M |
|
$25.61M |
|
$14.77M |
|
$14.08M |
|
$-0.69M |
|
$2.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.19 |
|
-- |
|
-- |
|
6.70 |
|
-1.18 |
|
100.00% |
|
-747.02% |
|
-747.02% |
|
-715.80% |
|
-3544.03% |
|
-3544.03% |
|
$-26.30M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
10.39 |
|
35.13 |
|
79.51% |
|
78.26% |
|
-226.06% |
|
-453.49% |
|
$-6.00 |
|
$-0.73 |
|
$-0.71 |
|